Comparison of the Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Lymphocyte to High-Density Lipoprotein Cholesterol Ratio for Predicting Metabolic Syndrome Among a Population in the Southern Coast of China

References

• Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–636. doi:10.1161/ATVBAHA.107.151092
   PubMed Web of Science ®Google Scholar
• McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36(1):14–20. doi:10.1016/j.clindermatol.2017.09.004
   PubMed Web of Science ®Google Scholar
• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z
   PubMed Web of Science ®Google Scholar
• Balci KG, Balci MM, Sen F, et al. The role of baseline indirect inflammatory markers in prediction of response to cardiac resynchronisation therapy. Kardiol Pol. 2016;74(2):119–126. doi:10.5603/KP.a2015.0142
   PubMedGoogle Scholar
• Lim HJ, Seo M-S, Shim J-Y, Kim KE, Shin YH, Lee YJ. The association between platelet count and metabolic syndrome in children and adolescents. Platelets. 2015;26(8):758–763. doi:10.3109/09537104.2014.995613
   PubMed Web of Science ®Google Scholar
• Yang H, Fu Y-Q, Yang B, et al. Positive association between the metabolic syndrome and white blood cell counts in Chinese. Asia Pac J Clin Nutr. 2017;26(1):141–147. doi:10.6133/apjcn.102015.13
   PubMed Web of Science ®Google Scholar
• Ertem AG, Yayla C, Acar B, et al. Relation between lymphocyte to monocyte ratio and short-term mortality in patients with acute pulmonary embolism. Clin Respir J. 2018;12(2):580–586. doi:10.1111/crj.2018.12.issue-2
   PubMed Web of Science ®Google Scholar
• Akboga MK, Canpolat U, Sahinarslan A, et al. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis. 2015;240(1):110–114. doi:10.1016/j.atherosclerosis.2015.02.051
   PubMed Web of Science ®Google Scholar
• Cockerill GW, Rye K-A, Gamble JRVadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15(11):1987–1994. doi:10.1161/01.ATV.15.11.1987
   PubMed Web of Science ®Google Scholar
• Wu S, Lin H, Zhang C, et al. Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. BMC Public Health. 2013;13:989. doi:10.1186/1471-2458-13-989
   PubMed Web of Science ®Google Scholar
• Akboga MK, Balci KG, Maden O, et al. Usefulness of monocyte to HDL-cholesterol ratio to predict high SYNTAX score in patients with stable coronary artery disease. Biomark Med. 2016;10(4):375–383. doi:10.2217/bmm-2015-0050
   PubMed Web of Science ®Google Scholar
• Berhane M, Melku M, Amsalu A, Enawgaw B, Getaneh Z, Asrie F. The role of neutrophil to lymphocyte count ratio in the differential diagnosis of pulmonary tuberculosis and bacterial community-acquired pneumonia: a Cross-Sectional Study at Ayder and Mekelle Hospitals, Ethiopia. Clin Lab. 2019;65(4). doi:10.7754/Clin.Lab.2018.180833
   PubMed Web of Science ®Google Scholar
• Stentz FB, Kitabchi AE. Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics. 2007;5(3–4):216–235. doi:10.1016/S1672-0229(08)60009-1
   PubMedGoogle Scholar
• Chen H, Xiong C, Shao X, et al. Lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome. Diabetes Metab Syndr Obes. 2019;12:2117–2123. doi:10.2147/DMSO
   PubMed Web of Science ®Google Scholar
• Nikolopoulou A, Kadoglou NP. Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev Cardiovasc Ther. 2012;10(7):933–939. doi:10.1586/erc.12.74
   PubMedGoogle Scholar
• Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–1132. doi:10.1016/j.jacc.2010.05.034
   PubMed Web of Science ®Google Scholar
• Akboga MK, Yalcin R, Sahinarslan A, Demirtas CY, Abaci A. Effect of serum YKL-40 on coronary collateral development and SYNTAX score in stable coronary artery disease. Int J Cardiol. 2016;224:323–327. doi:10.1016/j.ijcard.2016.09.042
   PubMed Web of Science ®Google Scholar
• Wang YY, Lin S-Y, Liu P-H, et al. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications. 2004;18(6):322–327. doi:10.1016/S1056-8727(04)00003-0
   PubMedGoogle Scholar
• Lao XQ, Neil Thomas G, Jiang C, et al. White blood cell count and the metabolic syndrome in older Chinese: the Guangzhou Biobank Cohort Study. Atherosclerosis. 2008;201(2):418–424. doi:10.1016/j.atherosclerosis.2007.12.053
   PubMed Web of Science ®Google Scholar
• Tanigawa T, Iso H, Yamagishi K, et al. Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men. Atherosclerosis. 2004;173(2):295–300. doi:10.1016/j.atherosclerosis.2003.12.019
   PubMedGoogle Scholar
• Kim JA, CHOI YS, HONG JI, et al. Association of metabolic syndrome with white blood cell subtype and red blood cells. Endocr J. 2006;53(1):133–139. doi:10.1507/endocrj.53.133
   PubMedGoogle Scholar
• Tamariz LJ, Young JH, Pankow JS, et al. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 2008;168(10):1153–1160. doi:10.1093/aje/kwn243
   PubMed Web of Science ®Google Scholar
• Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10):1638–1643. doi:10.1016/j.jacc.2005.02.054
   PubMed Web of Science ®Google Scholar
• Shankar A, Klein BE, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens. 2004;17(3):233–239. doi:10.1016/j.amjhyper.2003.11.005
   PubMed Web of Science ®Google Scholar
• Pasini E, Flati V, Paiardi S, et al. Intracellular molecular effects of insulin resistance in patients with metabolic syndrome. Cardiovasc Diabetol. 2010;9:46. doi:10.1186/1475-2840-9-46
   PubMedGoogle Scholar
• Bersch N, Groopman JE, Golde DW. Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro. J Clin Endocrinol Metab. 1982;55(6):1209–1211. doi:10.1210/jcem-55-6-1209
   PubMedGoogle Scholar
• Ghattas A, Griffiths HR, Devitt A, et al. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol. 2013;62(17):1541–1551. doi:10.1016/j.jacc.2013.07.043
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ. The anti inflammatory effects of high density lipoproteins. Curr Med Chem. 2009;16(6):667–675. doi:10.2174/092986709787458425
   PubMed Web of Science ®Google Scholar
• Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28(11):2071–2077. doi:10.1161/ATVBAHA.108.168690
   PubMed Web of Science ®Google Scholar
• Rohatgi A. High-density lipoprotein function measurement in human studies: focus on cholesterol efflux capacity. Prog Cardiovasc Dis. 2015;58(1):32–40. doi:10.1016/j.pcad.2015.05.004
   PubMed Web of Science ®Google Scholar
• Sur G, Floca E, Kudor-Szabadi L, et al. The relevance of inflammatory markers in metabolic syndrome. Maedica (Buchar). 2014;9(1):15–18.
   PubMedGoogle Scholar
• Surendar J, Indulekha K, Mohan V, Pradeepa R. Association of neutrophil-lymphocyte ratio with metabolic syndrome and its components in Asian Indians (CURES-143). J Diabetes Complications. 2016;30(8):1525–1529. doi:10.1016/j.jdiacomp.2016.08.006
   PubMed Web of Science ®Google Scholar
• Furuncuoglu Y, Tulgar S, Dogan AN, Cakar S, Tulgar YK, Cakiroglu B. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016;20(7):1300–1306.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Trabert B, Katki HA, et al. Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2840–2849. doi:10.1158/1055-9965.EPI-14-0699-T
   PubMedGoogle Scholar
• Vuong J, Qiu Y, La M, Clarke G, Swinkels DW, Cembrowski G. Reference intervals of complete blood count constituents are highly correlated to waist circumference: should obese patients have their own “normal values?” Am J Hematol. 2014;89(7):671–677. doi:10.1002/ajh.23713
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Ucan B, Sayki M, et al. Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesity. Diabetes Metab Syndr. 2015;9(4):299–304. doi:10.1016/j.dsx.2014.04.009
   PubMedGoogle Scholar
• Bahadir A, Baltaci D, Turker Y, et al. Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? Anatol J Cardiol. 2015;15(10):816–822. doi:10.5152/AnatolJCardiol.
   PubMed Web of Science ®Google Scholar
• Syauqy A, Hsu C-Y, Rau H-H, et al. Association of dietary patterns, anthropometric measurements, and metabolic parameters with C-reactive protein and neutrophil-to-lymphocyte ratio in middle-aged and older adults with metabolic syndrome in Taiwan: a cross-sectional study. Nutr J. 2018;17(1):106. doi:10.1186/s12937-018-0417-z
   PubMedGoogle Scholar
• Khan IM, Pokharel Y, Dadu RT, et al. Postprandial monocyte activation in individuals with metabolic syndrome. J Clin Endocrinol Metab. 2016;101(11):4195–4204. doi:10.1210/jc.2016-2732
   PubMedGoogle Scholar
• Johnsen SH, Fosse E, Joakimsen O, et al. Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline the Tromso Study. Stroke. 2005;36(4):715–719. doi:10.1161/01.STR.0000158909.07634.83
   PubMedGoogle Scholar
• Yayla C, Akboğa MK, Gayretli Yayla K, et al. A novel marker of inflammation in patients with slow coronary flow: lymphocyte-to-monocyte ratio. Biomark Med. 2016;10(5):485–493. doi:10.2217/bmm-2016-0022
   PubMed Web of Science ®Google Scholar
• Yue S, Zhang J, Wu J, Teng W, Liu L, Chen L. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Environ Res Public Health. 2015;12(8):10009–10019. doi:10.3390/ijerph120810009
   PubMed Web of Science ®Google Scholar
• Gary T, Pichler M, Belaj K, et al. Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. Int J Clin Pract. 2014;68(12):1483–1487. doi:10.1111/ijcp.2014.68.issue-12
   PubMedGoogle Scholar
• Vahit D, Mehmet KA, Samet Y, Hüseyin E. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. Biomark Med. 2017;11(7):535–540. doi:10.2217/bmm-2016-0380
   PubMedGoogle Scholar
• Acikgoz SK, Açıkgöz E, Şensoy B, Topal S, Aydoğdu S. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction. Cardiol J. 2016;23(5):505–512. doi:10.5603/CJ.a2016.0026
   PubMed Web of Science ®Google Scholar